Breadcrumb
- Home
- Learning and Research
- Upcoming Events
- Sex Matters: Translational Advances In Respiratory...
Sex Matters: Translational Advances in Respiratory and PAH Research
20 April 2026, 16:00 BST
Join us for the first, Women's Health Task Force, webinar of 2026, exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.
Hosted by the PVRI Women’s Health Task Force, this webinar is part of a global effort to advance knowledge, research, and care for women affected by PH.
Presentations
- Intermittent hypoxia modulates in a sex-specific manner the transcriptional profile of endothelial cell in pulmonary arterial hypertension by Sanda Predescu
- The role of Sex as a biological variable in the developing lung endothelium by Krithika Lingappan
Our webinars are free and open to all.
Our speakers
Krithika Lingappan is a neonatologist and physician-scientist whose laboratory focuses on how biological sex shapes endothelial and immune responses in the developing lung and contributes to bronchopulmonary dysplasia and other prematurity-related morbidities.
Her work integrates murine models, single-cell and spatial transcriptomics, and human endothelial and macrophage studies to define sex chromosome driven mechanisms of neonatal hyperoxic lung injury, with a particular emphasis on sex-specific differences in the pulmonary microvasculature and distal lung capillary endothelium.
Sanda Predescu is a researcher at Rush University Medical Center in Chicago, specialising in the molecular mechanisms of pulmonary hypertension (PH). Her work focuses on endothelial cell function and how its disruption drives vascular remodelling and disease progression.
She has made key contributions to understanding intersectorin-1 signalling, sex differences in PH, and the role of long noncoding RNAs in vascular disease. Her research bridges basic science and clinical application, with the aim of identifying new therapeutic targets.
Our speakers & hosts
More from IDDI Workstream and Task Force Learning
Our IDDI Workstreams & Task Forces are actively finding practical solutions to the key challenges facing Pulmonary Hypertension (PH) physicians, academics, industry, and regulators; raising awareness of Pulmonary Vascular Disease (PVD); and addressing key challenges in its causes, effects, and treatment.